NHLBI at the 20th Annual Non-Dilutive Funding Summit
The 20th Non-Dilutive Funding Summit brought together hundreds of life science industry leaders with representatives from some of the leading funding agencies including DARPA, CDMRP, ATI, NHLBI, NSCEB, NIA and more, giving attendees the opportunity to learn more in-depth about what non-dilutive funding opportunities are available and relevant for their R&D directly from the funding agencies.
Additionally, the 2024 FreeMind Elite honorees took to the stage to present about their companies research and pipelines and their journey to securing non-dilutive funding.
This free summit is hosted by the FreeMind Group. FreeMind helps companies secure non-dilutive funding for life science R&D and wins over $100 million each year for clients. Follow us on LinkedIn or get our newsletter for news about non-dilutive funding opportunities, announcements about conferences with the best partnering, and discounts for those conferences.
National Heart, Lung and Blood Institute (NHLBI)
The National Heart, Lung, and Blood Institute (NHLBI) is a division of the U.S. National Institutes of Health (NIH) dedicated to advancing research, education, and prevention of diseases affecting the heart, lungs, blood, and sleep-related disorders. Established in 1948, NHLBI supports cutting-edge medical research, clinical trials, and public health initiatives to improve cardiovascular, pulmonary, and hematologic health. The institute also provides funding opportunities for scientists and fosters partnerships to accelerate discoveries and their translation into improved patient care. NHLBI plays a critical role in guiding evidence-based policies and health recommendations to address global health challenges
Dr. Stephanie Davis, Small Business Program Coordinator
Stephanie received her B.S. in Biochemistry and Molecular Biology in 2012 from Florida Southern College. She received her M.S. in Medical Sciences (2015) and her Ph.D. in Molecular Pharmacology (2016) from the University of South Florida. Stephanie was a postdoctoral scholar at the University of Kentucky in the Department of Neurology. In addition to her postdoctoral appointment, she also interned part-time with the UK Office of Technology Commercialization from January to July 2019. Before joining the Innovation Office, Stephanie was selected for the 2019-2020 Executive Branch AAAS Science and Technology Policy Fellows Program, where she served as a Program Manager in the National Institute on Aging Office of Small Business Research. She has served as the National Heart Lung and Blood Institute Small Business Program Coordinator since December 2020.
